AMGN analyst scorecard · Amgen
66 rating changes on AMGN in the last 12 months. 68% of bullish calls were right at 30 days; 11% of bearish ones. Street grade C on 28 scored calls. Consensus target $388, 2% above the last close.
Graded through 2026-09-14 · last close $379.63 (2026-09-14). Rebuilt every morning.
Holds on AMGN, read: 2 cut to or raised to Hold (graded as the change) · 4 Holds whose target leaned 10%+ one way (graded that way, 25.0% right) · 32 true Holds, not graded.
Firm by firm
| Firm | Calls | Scored | Right | Accuracy | Grade | Avg 30d | Avg 90d | Latest | Date | Target |
|---|---|---|---|---|---|---|---|---|---|---|
| UBS | 4 | 4 | 3 | 75.0% | A | +7.2% | +0.2% | Buy | 2026-08-05 | $440 |
| Wells Fargo | 5 | 1 | 1 | — | — | +1.7% | +4.4% | Equal-Weight | 2026-09-04 | $435 |
| Goldman Sachs | 1 | 1 | 1 | — | — | +7.2% | — | Buy | 2026-08-05 | $450 |
| TD Cowen | 1 | 1 | 1 | — | — | +7.2% | — | Buy | 2026-08-05 | $452 |
| Oppenheimer | 1 | 1 | 1 | — | — | +7.2% | — | Outperform | 2026-08-05 | $450 |
| Scotiabank | 1 | 1 | 1 | — | — | +7.2% | — | Sector Outperform | 2026-08-05 | $450 |
| RBC Capital | 1 | 1 | 1 | — | — | +7.2% | — | Outperform | 2026-08-05 | $400 |
| BMO Capital | 3 | 2 | 1 | — | — | +1.0% | +9.1% | Market Perform | 2026-09-08 | $450 |
| Argus Research | 3 | 2 | 1 | — | — | +1.0% | +7.0% | Buy | 2026-08-19 | $460 |
| Bernstein | 2 | 2 | 1 | — | — | +5.3% | +5.8% | Market Perform | 2026-08-06 | $345 |
| Leerink Partners | 2 | 2 | 1 | — | — | -1.8% | +0.6% | Outperform | 2026-02-04 | $355 |
| Piper Sandler | 4 | 3 | 1 | — | — | -2.5% | +6.5% | Overweight | 2026-08-20 | $457 |
| Morgan Stanley | 7 | 1 | 0 | — | — | +3.3% | +6.3% | Equal-Weight | 2026-08-19 | $362 |
| Cantor Fitzgerald | 6 | 0 | 0 | — | — | +2.2% | +3.8% | Neutral | 2026-09-08 | $400 |
| Guggenheim | 5 | 0 | 0 | — | — | +0.9% | +2.0% | Neutral | 2026-08-10 | $388 |
| Truist Securities | 4 | 1 | 0 | — | — | +7.7% | +11.8% | Hold | 2026-08-05 | $362 |
| Barclays | 3 | 0 | 0 | — | — | -1.2% | -10.0% | Equal-Weight | 2026-08-14 | $380 |
| Mizuho | 2 | 1 | 0 | — | — | +6.8% | +9.1% | Neutral | 2026-08-18 | $352 |
| Citigroup | 2 | 0 | 0 | — | — | -1.7% | -10.0% | Neutral | 2026-08-07 | $405 |
| Canaccord Genuity | 2 | 0 | 0 | — | — | +2.5% | +5.6% | Hold | 2026-08-05 | $384 |
| Bank of America | 2 | 2 | 0 | — | — | +6.9% | +22.0% | Underperform | 2026-08-05 | $317 |
| Freedom Broker | 2 | 1 | 0 | — | — | -2.8% | +0.2% | Hold | 2026-02-12 | $375 |
| HSBC | 1 | 0 | 0 | — | — | — | — | Hold | 2026-09-10 | $425 |
| Baird | 1 | 1 | 0 | — | — | +7.2% | — | Underperform | 2026-08-05 | $230 |
| Jefferies | 1 | 0 | 0 | — | — | -5.3% | -7.9% | Hold | 2026-03-10 | $350 |
Dimmed rows have fewer than 4 scored calls on AMGN — too few to grade.
Every call, last 12 months
| Date | Firm | Change | Action | Graded as | Price at call | Run before | +30d | +60d | +90d | Target · 90d check | Hit |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | HSBC | Buy → Hold | downgrade | Bearish · cut to Hold | $382.47 | -7.7% | — | — | — | $425 | pending |
| 2026-09-08 | BMO Capital | Outperform → Market Perform | downgrade | Bearish · cut to Market Perform | $393.17 | -4.3% | — | — | — | $450 | pending |
| 2026-09-08 | Cantor Fitzgerald | Neutral → Neutral | reiterated | True hold · target +1% | $393.17 | -4.3% | — | — | — | $400 | not graded |
| 2026-09-04 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target +0% | $437.23 | +7.2% | — | — | — | $435 | not graded |
| 2026-08-20 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $433.73 | +18.4% | — | — | — | $457 | pending |
| 2026-08-19 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | Leans bearish · Equal-Weight, target -18% | $442.36 | +21.5% | — | — | — | $362 | pending |
| 2026-08-19 | Argus Research | Buy → Buy | maintained | Bullish | $442.36 | +21.5% | — | — | — | $460 | pending |
| 2026-08-18 | Mizuho | Neutral → Neutral | maintained | Leans bearish · Neutral, target -17% | $425.28 | +16.1% | — | — | — | $352 | pending |
| 2026-08-18 | Cantor Fitzgerald | Neutral → Neutral | maintained | True hold · target -5% | $425.28 | +16.1% | — | — | — | $400 | not graded |
| 2026-08-14 | Barclays | Equal-Weight → Equal-Weight | maintained | True hold · target -8% | $415.21 | +15.9% | -8.6% | — | — | $380 | not graded |
| 2026-08-10 | Guggenheim | Neutral → Neutral | maintained | True hold · target -7% | $417.20 | +14.8% | -6.2% | — | — | $388 | not graded |
| 2026-08-07 | Citigroup | Neutral → Neutral | maintained | True hold · target -1% | $410.95 | +11.7% | -4.3% | — | — | $405 | not graded |
| 2026-08-06 | Bernstein | Market Perform → Market Perform | maintained | Leans bearish · Market Perform, target -14% | $404.85 | +10.0% | -2.9% | — | — | $345 | ✓ |
| 2026-08-05 | Baird | Underperform → Underperform | maintained | Bearish | $407.83 | +11.3% | +7.2% | — | — | $230 | ✗ |
| 2026-08-05 | Canaccord Genuity | Hold → Hold | maintained | True hold · target -5% | $407.83 | +11.3% | +7.2% | — | — | $384 | not graded |
| 2026-08-05 | Bank of America | Underperform → Underperform | maintained | Bearish | $407.83 | +11.3% | +7.2% | — | — | $317 | ✗ |
| 2026-08-05 | Goldman Sachs | Buy → Buy | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $450 | ✓ |
| 2026-08-05 | UBS | Buy → Buy | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $440 | ✓ |
| 2026-08-05 | TD Cowen | Buy → Buy | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $452 | ✓ |
| 2026-08-05 | Truist Securities | Hold → Hold | maintained | Leans bearish · Hold, target -11% | $407.83 | +11.3% | +7.2% | — | — | $362 | ✗ |
| 2026-08-05 | Oppenheimer | Outperform → Outperform | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $450 | ✓ |
| 2026-08-05 | Scotiabank | Sector Outperform → Sector Outperform | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $450 | ✓ |
| 2026-08-05 | RBC Capital | Outperform → Outperform | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $400 | ✓ |
| 2026-08-05 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target -1% | $407.83 | +11.3% | +7.2% | — | — | $400 | not graded |
| 2026-08-05 | BMO Capital | Outperform → Outperform | maintained | Bullish | $407.83 | +11.3% | +7.2% | — | — | $450 | ✓ |
| 2026-07-29 | Barclays | Equal-Weight → Equal-Weight | maintained | True hold · target -7% | $387.64 | +7.5% | +11.6% | — | — | $360 | not graded |
| 2026-07-13 | UBS | Buy → Buy | maintained | Bullish | $360.45 | +1.5% | +15.5% | +4.7% | — | $420 | ✓ |
| 2026-07-13 | Guggenheim | Neutral → Neutral | maintained | True hold · target -4% | $360.45 | +1.5% | +15.5% | +4.7% | — | $343 | not graded |
| 2026-07-08 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target -9% | $367.99 | +6.4% | +11.7% | +6.8% | — | $333 | not graded |
| 2026-07-07 | Truist Securities | Hold → Hold | maintained | True hold · target -7% | $368.10 | +5.3% | +10.0% | +6.8% | — | $340 | not graded |
| 2026-07-06 | Cantor Fitzgerald | Neutral → Neutral | reiterated | True hold · target -4% | $366.44 | +4.8% | +11.3% | +19.3% | — | $350 | not graded |
| 2026-06-16 | Mizuho | Neutral → Neutral | maintained | Leans bearish · Neutral, target -12% | $347.84 | +6.6% | +6.8% | +20.6% | +9.1% | $303 missed | ✗ |
| 2026-06-10 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +0% | $337.73 | +2.5% | +7.6% | +23.5% | +16.4% | $340 missed | not graded |
| 2026-05-20 | Argus Research | Buy → Buy | maintained | Bullish | $331.57 | -5.3% | +4.0% | +9.8% | +28.3% | $375 hit | ✓ |
| 2026-05-14 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $336.23 | -4.2% | +4.2% | +7.2% | +23.8% | $427 hit | ✓ |
| 2026-05-04 | Guggenheim | Neutral → Neutral | maintained | True hold · target +5% | $323.85 | -6.9% | +4.4% | +13.2% | +17.0% | $340 hit | not graded |
| 2026-05-01 | Truist Securities | Hold → Hold | maintained | True hold · target +0% | $329.82 | -6.6% | -0.2% | +9.8% | +17.5% | $327 missed | not graded |
| 2026-04-21 | Canaccord Genuity | Hold | initiated | True hold · target +6% | $344.86 | -0.8% | -2.2% | -0.0% | +5.6% | $366 hit | not graded |
| 2026-04-13 | UBS | Buy → Buy | maintained | Bullish | $349.82 | -4.5% | -3.8% | +1.5% | +3.0% | $400 missed | ✗ |
| 2026-04-10 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target -7% | $351.02 | -7.0% | -6.1% | -1.8% | +3.6% | $326 missed | not graded |
| 2026-04-09 | Guggenheim | Neutral → Neutral | maintained | True hold · target -1% | $355.60 | -5.3% | -7.3% | -2.8% | +3.5% | $351 hit | not graded |
| 2026-04-08 | Cantor Fitzgerald | Neutral → Neutral | reiterated | True hold · target +0% | $349.81 | -7.2% | -5.2% | -1.2% | +5.2% | $350 missed | not graded |
| 2026-03-10 | Jefferies | Hold | initiated | True hold · target -6% | $375.43 | -2.3% | -5.3% | -12.2% | -7.9% | $350 hit | not graded |
| 2026-02-20 | Barclays | Equal-Weight | initiated | True hold · target -6% | $374.75 | +9.1% | -6.7% | -8.0% | -10.0% | $350 hit | not graded |
| 2026-02-19 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target +0% | $375.50 | +13.4% | -6.8% | -6.8% | -11.7% | $375 missed | not graded |
| 2026-02-18 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $379.73 | +14.9% | -8.4% | -7.8% | -12.9% | $432 missed | ✗ |
| 2026-02-12 | Freedom Broker | Buy → Hold | downgrade | Bearish · cut to Hold | $366.20 | +12.9% | +0.0% | -4.5% | -8.1% | $375 missed | ✗ |
| 2026-02-06 | Argus Research | Buy → Buy | maintained | Bullish | $384.32 | +12.5% | -1.9% | -11.5% | -14.4% | $400 missed | ✗ |
| 2026-02-06 | Guggenheim | Neutral → Neutral | maintained | True hold · target -9% | $384.32 | +12.5% | -1.9% | -11.5% | -14.4% | $347 hit | not graded |
| 2026-02-04 | Citigroup | Neutral → Neutral | maintained | True hold · target -5% | $366.20 | +14.2% | +0.9% | -6.5% | -10.0% | $345 hit | not graded |
| 2026-02-04 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | Leans bearish · Equal-Weight, target -15% | $366.20 | +14.2% | +0.9% | -6.5% | -10.0% | $309 close | ✗ |
| 2026-02-04 | Cantor Fitzgerald | Neutral → Neutral | maintained | True hold · target -4% | $366.20 | +14.2% | +0.9% | -6.5% | -10.0% | $350 hit | not graded |
| 2026-02-04 | Leerink Partners | Outperform → Outperform | maintained | Bullish | $366.20 | +14.2% | +0.9% | -6.5% | -10.0% | $355 hit | ✓ |
| 2026-01-26 | UBS | Buy → Buy | maintained | Bullish | $349.69 | +5.0% | +9.9% | -0.3% | -2.7% | $390 missed | ✓ |
| 2026-01-20 | Bernstein | Outperform → Market Perform | downgrade | Bearish · cut to Market Perform | $331.00 | +1.1% | +13.4% | +5.7% | +5.8% | $335 hit | ✗ |
| 2026-01-08 | Truist Securities | Hold → Hold | maintained | True hold · target -3% | $330.11 | +5.2% | +13.8% | +14.2% | +6.0% | $319 missed | not graded |
| 2025-12-12 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target -4% | $317.74 | -5.5% | +2.5% | +14.8% | +15.8% | $304 missed | not graded |
| 2025-12-10 | Wells Fargo | Equal-Weight → Equal-Weight | maintained | True hold · target +3% | $315.38 | -2.6% | +3.4% | +19.2% | +19.0% | $325 hit | not graded |
| 2025-12-03 | BMO Capital | Outperform → Outperform | maintained | Bullish | $345.42 | +16.6% | -5.2% | -0.2% | +9.1% | $372 hit | ✗ |
| 2025-11-27 | Leerink Partners | Outperform → Outperform | maintained | Bullish | $345.46 | +18.3% | -4.6% | +1.2% | +11.2% | $305 missed | ✗ |
| 2025-11-14 | Piper Sandler | Overweight → Overweight | maintained | Bullish | $336.74 | +13.3% | -3.4% | -3.7% | +8.8% | $381 hit | ✗ |
| 2025-11-12 | Freedom Broker | Hold → Hold | maintained | True hold · target +7% | $336.28 | +15.0% | -5.5% | -3.2% | +8.4% | $360 hit | not graded |
| 2025-11-06 | Cantor Fitzgerald | Neutral → Neutral | maintained | True hold · target +0% | $315.59 | +6.8% | +1.8% | +1.6% | +16.0% | $315 missed | not graded |
| 2025-11-05 | Morgan Stanley | Equal-Weight → Equal-Weight | maintained | True hold · target +2% | $319.86 | +8.8% | +3.1% | +0.3% | +5.9% | $329 hit | not graded |
| 2025-11-05 | Wells Fargo | Overweight → Overweight | maintained | Bullish | $319.86 | +8.8% | +3.1% | +0.3% | +5.9% | $300 missed | ✓ |
| 2025-09-26 | Bank of America | Underperform → Underperform | maintained | Bearish | $272.98 | — | +6.7% | +25.0% | +22.0% | $272 missed | ✗ |
Also in Biotech
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How the grading works
Every sell-side rating change from the last 365 days is priced the day it lands and checked again 30, 60 and 90 days later. A call is a hit when the stock moved in the called direction at 30 days. Buy- and Sell-side ratings call their own direction. A Hold is read, not waved through: a downgrade to Hold is graded as a bearish call and an upgrade to Hold as a bullish one, and a maintained Hold whose price target sits 10%+ above the price leans bullish (10%+ below, leans bearish) and is graded that way. A Hold with a target close to the price is a true Hold and is not graded at all. Every call with a price target also gets a target check 90 days later: hit (reached it or within 5%), close (covered at least half the distance) or missed. A firm's accuracy on a single name prints only after 4 scored calls, and a firm gets its own page only after 10 scored calls across every covered name — below that a percentage is noise. "Run before the call" is the stock's move over the 30 calendar days before the rating landed. Data: Yahoo Finance rating history and daily closes, rebuilt each morning. Nothing on this page is advice.
Get the 7 AM brief
The AM take, today's docket and the Street's calls — one email, weekdays, before the open.